California Public Employees Retirement System Clovis Oncology, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$5.02 - $7.05 $846,873 - $1.19 Million	-168,700 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$4.13 - $6.41 $78,399 - $121,681	-18,983 Reduced 10.11%	168,700 $810,000
Q3 2020 Nov 05, 2020	BUY	$4.82 - $7.72 $199,466 - $319,476	41,383 Added 28.29%	187,683 $1.09 Million
Q2 2020 Aug 12, 2020	BUY	$5.69 - $9.69 $248,653 - $423,453	43,700 Added 42.59%	146,300 $988,000
Q1 2020 May 12, 2020	SELL	$3.77 - $11.0 $514,665 - $1.5 Million	-136,516 Reduced 57.09%	102,600 $653,000
Q4 2019 Jan 27, 2020	BUY	$3.0 - $16.43 $518,448 - $2.84 Million	172,816 Added 260.66%	239,116 $2.49 Million
Q3 2019 Oct 31, 2019	BUY	$3.93 - $15.35 $36,549 - $142,755	9,300 Added 16.32%	66,300 $261,000
Q2 2019 Aug 15, 2019	SELL	$12.81 - $25.67 $11,529 - $23,103	-900 Reduced 1.55%	57,000 $848,000
Q1 2019 May 03, 2019	SELL	$17.66 - $30.28 $28,256 - $48,448	-1,600 Reduced 2.69%	57,900 $1.44 Million
Q4 2018 Feb 08, 2019	SELL	$11.63 - $32.67 $68,617 - $192,753	-5,900 Reduced 9.02%	59,500 $1.07 Million
Q3 2018 Nov 13, 2018	SELL	$29.37 - $49.48 $158,598 - $267,192	-5,400 Reduced 7.63%	65,400 $1.92 Million
Q2 2018 Aug 15, 2018	SELL	$42.06 - $62.4 $593,046 - $879,840	-14,100 Reduced 16.61%	70,800 $3.22 Million
Q1 2018 May 11, 2018	SELL	$50.12 - $67.72 $615,674 - $831,872	-12,284 Reduced 12.64%	84,900 $4.48 Million
Q4 2017 Feb 06, 2018	BUY	$57.69 - $84.58 $3.68 Million - $5.4 Million	63,800 Added 191.11%	97,184 $6.61 Million
Q3 2017 Nov 15, 2017	BUY	$67.17 - $84.81 $2.24 Million - $2.83 Million	33,384	33,384 $2.75 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account